MONTE ROSA THERAPEUTICS, INC. <GLUE.O>: UBS RAISES TARGET PRICE TO $19 FROM $17

Reuters2026/10/12 13:40

By:Reuters

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

RBC DOWNGRADES US MATERIALS SECTOR TO MARKET WEIGHT FROM OVERWEIGHT

Reuters•2026/10/14 05:26

Iran Wants Higher Oil Before the Midterms: Can Trump Stop $100 Crude?

BeInCrypto•2026/10/14 05:09

TIMBERCREEK FINANCIAL CORP <TF.TO>: TD COWEN CUTS TARGET PRICE TO C$5.5 FROM C$6

Reuters•2026/10/14 03:45

Venture Head Says Goldman and JPMorgan Are Becoming AI Stocks

BeInCrypto•2026/10/14 02:15